Want to see TSE:NLH full AI Analyst Report?
Total Valuation
Nova Leap Health has a market cap or net worth of C$51.52M. The enterprise value is C$42.23.
Market CapC$51.52M
Enterprise ValueC$42.23
Share Statistics
Nova Leap Health has 87,314,255 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding87,314,255
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nova Leap Health’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is 5.13%.
Return on Equity (ROE)-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)5.13%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee59.18K
Profits Per Employee-350.95
Employee Count541
Asset Turnover1.37
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Nova Leap Health is 27.4. Nova Leap Health’s PEG ratio is 0.81.
PE Ratio27.4
PS Ratio0.56
PB Ratio0.94
Price to Fair Value0.94
Price to FCF12.58
Price to Operating Cash Flow19.03
PEG Ratio0.81
Income Statement
In the last 12 months, Nova Leap Health had revenue of 32.02M and earned -193.19K in profits. Earnings per share was >-0.01.
Revenue32.02M
Gross Profit11.85M
Operating Income1.13M
Pretax Income-134.36K
Net Income-193.19K
EBITDA1.97M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was 1.91M and capital expenditures -243.02K, giving a free cash flow of 1.95M billion.
Operating Cash Flow1.91M
Free Cash Flow1.95M
Free Cash Flow per Share0.02
Dividends & Yields
Nova Leap Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.26
52-Week Price Change81.25%
50-Day Moving Average0.44
200-Day Moving Average0.36
Relative Strength Index (RSI)76.13
Average Volume (3m)21.45K
Important Dates
Nova Leap Health upcoming earnings date is Nov 5, 2026, Before Open (Confirmed).
Last Earnings DateAug 7, 2026
Next Earnings DateNov 5, 2026
Ex-Dividend Date―
Financial Position
Nova Leap Health as a current ratio of 0.96, with Debt / Equity ratio of 22.94%
Current Ratio0.96
Quick Ratio0.96
Debt to Market Cap0.11
Net Debt to EBITDA0.73
Interest Coverage Ratio3.16
Taxes
In the past 12 months, Nova Leap Health has paid 58.82K in taxes.
Income Tax58.82K
Effective Tax Rate-0.44
Enterprise Valuation
Nova Leap Health EV to EBITDA ratio is 9.75, with an EV/FCF ratio of 13.60.
EV to Sales0.60
EV to EBITDA9.75
EV to Free Cash Flow13.60
EV to Operating Cash Flow13.60
Balance Sheet
Nova Leap Health has C$1.44M in cash and marketable securities with C$4.45M in debt, giving a net cash position of -C$3.01M billion.
Cash & Marketable SecuritiesC$1.44M
Total DebtC$4.45M
Net Cash-C$3.01M
Net Cash Per Share-C$0.03
Tangible Book Value Per ShareC$0.02
Margins
Gross margin is 38.95%, with operating margin of 3.51%, and net profit margin of -0.60%.
Gross Margin38.95%
Operating Margin3.51%
Pretax Margin-0.42%
Net Profit Margin-0.60%
EBITDA Margin6.16%
EBIT Margin3.51%
Analyst Forecast
The average price target for Nova Leap Health is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast18.35%
EPS Growth Forecast1021.05%